Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study
Top Cited Papers
Open Access
- 25 July 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (7), e0198681
- https://doi.org/10.1371/journal.pone.0198681
Abstract
E-cigarettes are promoted as healthier alternatives to conventional cigarettes. Many cigarette smokers use both products. It is unknown whether the additional use of e-cigarettes among cigarette smokers (dual users) is associated with reduced exposure to tobacco-related health risks. Cross-sectional analysis was performed using baseline data from the Health eHeart Study, among English-speaking adults, mostly from the United States. Cigarette use (# cigarettes/day) and/or e-cigarette use (# days, # cartridges, and # puffs) were compared between cigarette only users vs. dual users. Additionally, we examined cardiopulmonary symptoms/ conditions across product use: no product (neither), e-cigarettes only, cigarettes only, and dual use. Among 39,747 participants, 573 (1.4%) reported e-cigarette only use, 1,693 (4.3%) reported cigarette only use, and 514 (1.3%) dual use. Dual users, compared to cigarette only users, reported a greater median (IQR) number of cigarettes per day, 10.0 (4.0–20.0) vs. 9.0 (3.0–15.0) (p < .0001), a lower (worse) median (IQR) SF-12 general health score, 3.3 (2.8–3.8) vs. 3.5 (2.8–3.9) (p = .0014), and a higher (worse) median (IQR) breathing difficulty score in the past month, 2.0 (1.0–2.0) vs. 1.0 (1.0–2.0) (p = .001). Of the 19 cardiopulmonary symptoms/ conditions, having a history of arrhythmia was significantly different between cigarette only users (14.2%) and dual users (17.8%) (p = .02). In this sample, dual use was not associated with reduced exposure to either (i) cigarettes, compared to cigarette only users or (ii) e-cigarettes, compared to e-cigarette only users. E-cigarette only use, compared to no product use, was associated with lower general health scores, higher breathing difficulty scores (typically and past month), and greater proportions of those who responded ‘yes’ to having chest pain, palpitations, coronary heart disease, arrhythmia, COPD, and asthma. These data suggest the added use of e-cigarettes alone may have contributed to cardiopulmonary health risks particularly respiratory health risks.Funding Information
- National Institutes of Health (1U2CEB021881)
- National Institutes of Health (2T32CA113710-11)
- Patient-Centered Outcomes Research Institute (PPRN-1306-04709)
This publication has 48 references indexed in Scilit:
- EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design StudyPLOS ONE, 2013
- Use of Electronic Cigarettes Among State Tobacco Cessation Quitline CallersNicotine & Tobacco Research, 2013
- Patterns of electronic cigarette use and user beliefs about their safety and benefits: An Internet surveyDrug and Alcohol Review, 2012
- Electronic Cigarettes As a Smoking-Cessation Tool: Results from an Online SurveyAmerican Journal of Preventive Medicine, 2011
- The reliability and predictive validity of the Heaviness of Smoking Index and its two components: Findings from the International Tobacco Control Four Country studyNicotine & Tobacco Research, 2010
- A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective EffectsCancer Epidemiology, Biomarkers & Prevention, 2010
- Electronic cigarettes: a survey of usersBMC Public Health, 2010
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of Internal Medicine, 2006
- Treatment of Tobacco Use and DependenceThe New England Journal of Medicine, 2002
- The PHQ-9Journal of General Internal Medicine, 2001